GANITE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ganite, and what generic alternatives are available?
Ganite is a drug marketed by Chapter 7 Trustee and is included in one NDA.
The generic ingredient in GANITE is gallium nitrate. There are sixteen drug master file entries for this compound. Additional details are available on the gallium nitrate profile page.
Summary for GANITE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 18 |
| Clinical Trials: | 2 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in GANITE? | GANITE excipients list |
| DailyMed Link: | GANITE at DailyMed |
Recent Clinical Trials for GANITE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Chris Goss | Phase 1 |
| Cystic Fibrosis Foundation Therapeutics | Phase 1 |
| Cystic Fibrosis Foundation | Phase 1 |
US Patents and Regulatory Information for GANITE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chapter 7 Trustee | GANITE | gallium nitrate | INJECTABLE;INJECTION | 019961-002 | Jan 17, 1991 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for GANITE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Chapter 7 Trustee | GANITE | gallium nitrate | INJECTABLE;INJECTION | 019961-002 | Jan 17, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for GANITE
See the table below for patents covering GANITE around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Canada | 1219210 | UTILISATION DE SELS DE GALLIUM POUR LE TRAITEMENT DES DESEQUILIBRES DE L'HOMEOSTASE CALCIQUE (USE OF GALLIUM SALTS TO TREAT DISORDERS OF CALCIUM HOMEOSTASIS) | ⤷ Try a Trial |
| Japan | S6112625 | GALLIUM SALT FOR CALCIUM CONSTANT DISEASE | ⤷ Try a Trial |
| Japan | S59205322 | THERAPEUTICAL DRUG FOR DISEASE ACCOMPANIED WITH CALCIUM EXCESSIVE DEMINUTION FROM BONE | ⤷ Try a Trial |
| Germany | 3376387 | ⤷ Try a Trial | |
| Japan | H0261924 | ⤷ Try a Trial | |
| European Patent Office | 0109564 | THE USE OF GALLIUM SALTS FOR THE MANUFACTURE OF PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISORDERS OF CALCIUM HOMEOSTASIS | ⤷ Try a Trial |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
